EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 350 filers reported holding EXELIXIS INC in Q4 2020. The put-call ratio across all filers is 2.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,904 | +13.3% | 224,433 | -0.9% | 0.04% | +20.0% |
| Q2 2023 | $4,328 | -5.5% | 226,493 | -4.0% | 0.04% | -10.3% |
| Q1 2023 | $4,579 | +8.5% | 235,911 | -10.3% | 0.04% | +2.6% |
| Q4 2022 | $4,220 | -99.9% | 263,119 | +8.8% | 0.04% | +2.7% |
| Q3 2022 | $3,791,000 | -22.9% | 241,742 | +2.3% | 0.04% | -19.6% |
| Q2 2022 | $4,918,000 | -6.7% | 236,229 | +1.6% | 0.05% | +12.2% |
| Q1 2022 | $5,272,000 | -38.3% | 232,559 | -50.2% | 0.04% | +28.1% |
| Q4 2021 | $8,544,000 | +80.8% | 467,390 | +109.1% | 0.03% | -20.0% |
| Q3 2021 | $4,726,000 | +5.4% | 223,562 | -9.2% | 0.04% | +11.1% |
| Q2 2021 | $4,485,000 | +330.0% | 246,152 | +433.0% | 0.04% | -7.7% |
| Q1 2021 | $1,043,000 | +4.7% | 46,182 | -6.9% | 0.04% | +2.6% |
| Q4 2020 | $996,000 | -16.7% | 49,614 | +1.4% | 0.04% | -26.9% |
| Q3 2020 | $1,196,000 | +1.4% | 48,912 | -1.6% | 0.05% | -5.5% |
| Q2 2020 | $1,180,000 | -5.5% | 49,690 | -31.5% | 0.06% | +77.4% |
| Q1 2020 | $1,249,000 | -3.5% | 72,503 | -1.3% | 0.03% | +29.2% |
| Q4 2019 | $1,294,000 | +6.6% | 73,442 | +7.0% | 0.02% | -7.7% |
| Q3 2019 | $1,214,000 | -12.8% | 68,665 | +5.4% | 0.03% | -21.2% |
| Q2 2019 | $1,393,000 | -15.7% | 65,176 | -6.2% | 0.03% | -17.5% |
| Q1 2019 | $1,653,000 | +22.6% | 69,468 | +1.4% | 0.04% | +5.3% |
| Q4 2018 | $1,348,000 | +77.8% | 68,537 | +60.1% | 0.04% | +100.0% |
| Q3 2018 | $758,000 | -50.5% | 42,797 | -39.9% | 0.02% | -48.6% |
| Q2 2018 | $1,532,000 | +10.7% | 71,207 | +14.0% | 0.04% | 0.0% |
| Q1 2018 | $1,384,000 | -21.2% | 62,473 | +8.1% | 0.04% | -22.9% |
| Q4 2017 | $1,757,000 | +32.7% | 57,785 | +5.7% | 0.05% | +17.1% |
| Q3 2017 | $1,324,000 | -0.2% | 54,644 | +1.4% | 0.04% | -4.7% |
| Q2 2017 | $1,327,000 | +117.5% | 53,887 | +91.6% | 0.04% | +43.3% |
| Q1 2017 | $610,000 | +45.6% | 28,130 | -0.0% | 0.03% | +57.9% |
| Q4 2016 | $419,000 | +34.3% | 28,135 | +15.4% | 0.02% | +5.6% |
| Q3 2016 | $312,000 | +20.5% | 24,373 | +0.2% | 0.02% | +20.0% |
| Q2 2016 | $259,000 | +172.6% | 24,322 | +2.5% | 0.02% | +66.7% |
| Q1 2016 | $95,000 | -22.1% | 23,731 | +9.9% | 0.01% | -40.0% |
| Q4 2015 | $122,000 | -8.3% | 21,593 | -8.8% | 0.02% | +7.1% |
| Q3 2015 | $133,000 | +75.0% | 23,684 | +16.8% | 0.01% | +100.0% |
| Q2 2015 | $76,000 | +49.0% | 20,281 | +2.5% | 0.01% | +16.7% |
| Q1 2015 | $51,000 | +88.9% | 19,783 | +4.1% | 0.01% | +50.0% |
| Q4 2014 | $27,000 | -6.9% | 19,012 | +0.1% | 0.00% | 0.0% |
| Q3 2014 | $29,000 | -54.7% | 18,988 | -0.0% | 0.00% | -60.0% |
| Q2 2014 | $64,000 | -8.6% | 18,997 | -4.1% | 0.01% | -16.7% |
| Q1 2014 | $70,000 | -40.2% | 19,810 | +3.9% | 0.01% | -40.0% |
| Q4 2013 | $117,000 | – | 19,069 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |